HIV Citation List: January 2 - January 15, 2015
PubMed Citations
1. Polymers Fight HIV: Potent (Pro)Drugs Identified through Parallel Automated Synthesis. Zuwala, K., A.A. Smith, A. Postma, C. Guerrero-Sanchez, P. Ruiz-Sanchis, J. Melchjorsen, M. Tolstrup, and A.N. Zelikin. Advanced Healthcare Materials, 2015. 4(1): p. 46-50. PMID[24811313].
[PubMed]. HIV_0102-011515.
2. Designed Transcription Activator-like Effector Proteins Efficiently Induced the Expression of Latent HIV-1 in Latently Infected Cells. Wang, X., P. Wang, Z. Fu, H. Ji, X. Qu, H. Zeng, X. Zhu, J. Deng, P. Lu, S. Zha, Z. Song, and H. Zhu. AIDS Research and Human Retroviruses, 2015. 31(1): p. 98-106. PMID[25403229].
[PubMed]. HIV_0102-011515.
3. Evaluation of anti-HIV-1 Mutagenic Nucleoside Analogues. Vivet-Boudou, V., C. Isel, Y. El Safadi, R.P. Smyth, G. Laumond, C. Moog, J.C. Paillart, and R. Marquet. Journal of Biological Chemistry, 2015. 290(1): p. 371-383. PMID[25398876].
[PubMed]. HIV_0102-011515.
4. Inhibition of HIV-1 Entry by the Tricyclic Coumarin GUT-70 through the Modification of Membrane Fluidity. Matsuda, K., S. Hattori, R. Kariya, Y. Komizu, E. Kudo, H. Goto, M. Taura, R. Ueoka, S. Kimura, and S. Okada. Biochemical and Biophysical Research Communications, 2015. PMID[25576356].
[PubMed]. HIV_0102-011515.
5. Isolation and Characterization of 2'-F-RNA Aptamers against Whole HIV-1 Subtype C Envelope Pseudovirus. London, G.M., B.M. Mayosi, and M. Khati. Biochemical and Biophysical Research Communications, 2015. 456(1): p. 428-433. PMID[25482445].
[PubMed]. HIV_0102-011515.
6. Design, Synthesis, and Biological Evaluation of Novel 2H-Pyran-2-one Derivatives as Potential HIV-1 Reverse Transcriptase Inhibitors. Defant, A., I. Mancini, R. Tomazzolli, and J. Balzarini. Archiv der Pharmazie, 2015. 348(1): p. 23-33. PMID[25523431].
[PubMed]. HIV_0102-011515.
ISI Web of Knowledge Citations
7. Carbocyclodipeptides as Modified Nucleosides: Synthesis and anti-HIV Activities. Chhikara, B.S., M.S. Rao, V.K. Rao, A. Kumar, K.W. Buckheit, R.W. Buckheit, and K. Parang. Canadian Journal of Chemistry, 2014. 92(12): p. 1145-1149. ISI[000346369900005].
[WOS]. HIV_0102-011515.
Patent Citations
8. Preparation of Fused Tricyclic Heterocyclic Compounds as HIV Integrase Inhibitors. Embrey, M.W., K. Babaoglu, A. Walji, P. Coleman, and J.S. Wai. Patent. 2014. 2014-US41464 2014200880: 76pp.
[Patent]. HIV_0102-011515.
9. Peptides with Antagonistic Activities against Natural CXC-chemokine Receptor 4 Mediated HIV-1 NL4-3 Infection and Other Diseases. Forssmann, W.-G., F. Kirchhoff, J. Muench, and L. Staendker. Patent. 2014. 2014-EP62252 2014198834: 39pp.
[Patent]. HIV_0102-011515.
10. A HIV-1 Fusion Inhibitor with Long Half-life. Jiang, S., L. Lu, W. Xu, R. Wang, and J. Huang. Patent. 2014. 2014-CN80953 2014206336: 29pp ; Chemical Indexing Equivalent to 159:600595 (CN).
[Patent]. HIV_0102-011515.